Answers are grounded in this paper and cite their sources.
Catalytic deoxygenation improves aromatic C-H amination in pharmaceuticals, suggesting a new pathway for radical generation.
The catalytic deoxygenation of N - OH bonds to generate N-centered radicals remains a significant challenge due to the high bond dissociation energy and reliance on stoichiometric auxiliaries or activators. Herein, we report a B(C₆F₅)₃-catalyzed photoinduced deoxygenation strategy that enables direct aromatic C(sp²)-H amination of alkylarenes using N-hydroxyphthalimides (NHPIs) as nitrogen sources. Mechanistic studies reveal that the in situ formation of a PhthN-O - B(C₆F₅)₃ anion intermediate facilitates an unusual energy transfer (EnT)-mediated N - O bond homolysis, generating a phthalimidyl radical (PhthN•) while regenerating the borane catalyst. This method overrides the conventional preference for benzylic C - H oxidation, achieving exclusive aromatic C - H amination with broad substrate scope, including electron-rich/poor alkylarenes, heteroarenes, and biomolecules. The catalytic protocol operates under mild conditions, avoids stoichiometric organic auxiliaries/activators, and produces H₂O as the sole byproduct, thus, making it a promising option to supplant existing strategies for arene amination. Applications in late-stage functionalization of pharmaceuticals and the synthesis of a nilotinib precursor highlight its synthetic utility. This study establishes B(C₆F₅)₃ as a versatile catalytic oxygen atom transfer (OAT) reagent in photochemistry, opening avenues for sustainable radical generation.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: